Literature DB >> 16000282

18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation.

Shu-Hang Ng1, Tzu-Chen Yen, Chun-Ta Liao, Joseph Tung-Chieh Chang, Sheng-Chieh Chan, Sheung-Fat Ko, Hung-Ming Wang, Ho-Fai Wong.   

Abstract

UNLABELLED: Accurate evaluation of primary tumors and cervical lymph node status of squamous cell carcinoma (SCC) of the oral cavity is important to treatment planning and prognosis prediction. In this prospective study, we evaluated the use of 18F-FDG PET, CT/MRI, and their visual correlation for the identification of primary tumors and cervical nodal metastases of SCC of the oral cavity with histologic correlation.
METHODS: One hundred twenty-four patients with pathologically proven diagnoses of oral cavity SCC underwent 18F-FDG PET and CT/MRI within 2 wk before surgery. We interpreted 18F-FDG PET, CT/MRI, and visually correlated 18F-FDG PET and CT/MRI separately to assess the primary tumors and their regional lymph node status. We recorded lymph node metastases according to the neck level system of imaging-based nodal classification. Histopathologic analysis was used as the gold standard for assessment of the primary tumors and lymph node involvement. We analyzed differences in sensitivity and specificity among the imaging modalities using the McNemar test. The receiver-operating-characteristic (ROC) curve and calculation of the area under the curve were used to evaluate their discriminative power.
RESULTS: The accuracy of 18F-FDG PET, CT/MRI, and their visual correlation for the identification of primary tumors was 98.4%, 87.1%, and 99.2%, respectively. The sensitivity of 18F-FDG PET for the identification of nodal metastases on a level-by-level basis was 22.1% higher than that of CT/MRI (74.7% vs. 52.6%, P < 0.001), whereas the specificity of 18F-FDG PET was 1.5% lower than that of CT/MRI (93.0% vs. 94.5%, P = 0.345). The sensitivity and specificity of the visual correlation of 18F-FDG PET and CT/MRI were 3.2% and 1.5% higher than those of 18F-FDG PET alone (77.9% vs. 74.7%, P = 0.25; 94.5% vs. 93.0%, P = 0.18, respectively). The area under the curve obtained from the ROC curve showed that 18F-FDG PET was significantly superior to CT/MRI for total nodal detection (0.896 vs. 0.801, P = 0.002), whereas the visual correlation of 18F-FDG PET and CT/MRI was modestly superior to 18F-FDG PET alone (0.913 vs. 0.896, P = 0.28).
CONCLUSION: 18F-FDG PET is superior to CT/MRI in the detection of cervical status of oral cavity SCC. The sensitivity of 18F-FDG PET for the detection of cervical nodal metastasis on a level-by-level basis was significantly higher than that of CT/MRI, whereas their specificities appeared to be similar. Visual correlation of 18F-FDG PET and CT/MRI showed a trend of increased diagnostic accuracy over 18F-FDG PET alone but without a statistically significant difference, and its sensitivity was still not high enough to replace pathologic lymph node staging based on neck dissection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16000282

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  74 in total

1.  Virtual 3-D ¹⁸F-FDG PET/CT panendoscopy for assessment of the upper airways of head and neck cancer patients: a feasibility study.

Authors:  Christian Buchbender; Jon Treffert; Götz Lehnerdt; Stefan Mattheis; Bernhard Geiger; Andreas Bockisch; Michael Forsting; Gerald Antoch; Till A Heusner
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-06-05       Impact factor: 9.236

Review 2.  Present and future role of FDG-PET/CT imaging in the management of head and neck carcinoma.

Authors:  Kazuhiro Kitajima; Yuko Suenaga; Kazuro Sugimura
Journal:  Jpn J Radiol       Date:  2015-10-27       Impact factor: 2.374

3.  [(18)F]-FDG PET/CT imaging for detection of nodal metastases in patients with squamous cell carcinoma of the pharynx and larynx: comparison with CT.

Authors:  Yuko Suenaga; Kazuhiro Kitajima; Tomonori Kanda; Naoki Otsuki; Ken-Ichi Nibu; Ryohei Sasaki; Tomoo Itoh; Kazuro Sugimura
Journal:  Jpn J Radiol       Date:  2015-12-15       Impact factor: 2.374

4.  [18F]FDG PET/MRI versus contrast-enhanced MRI in detecting regional HNSCC metastases.

Authors:  Filippo Crimì; Daniele Borsetto; Roberto Stramare; Roberto Di Carlo; Enzo Emauelli; Piero Nicolai; Carmelo Lacognata; Pietro Zucchetta; Giulia Oliveri; Arcangelo Merola; Valentina Bodanza; Laura Albertoni; Cristina Campi; Diego Cecchin
Journal:  Ann Nucl Med       Date:  2021-01-17       Impact factor: 2.668

5.  From anatomical to biological target volumes: the role of PET in radiation treatment planning.

Authors:  D A X Schinagl; J H A M Kaanders; W J G Oyen
Journal:  Cancer Imaging       Date:  2006-10-31       Impact factor: 3.909

Review 6.  Nodal imaging in the neck: recent advances in US, CT and MR imaging of metastatic nodes.

Authors:  Takashi Nakamura; Misa Sumi
Journal:  Eur Radiol       Date:  2007-01-25       Impact factor: 5.315

7.  Prognostic value of preoperative 18F-FDG PET/CT for primary head and neck squamous cell carcinoma.

Authors:  Young-Hoon Joo; Ie-Ryung Yoo; Kwang-Jae Cho; Jun-Ook Park; In-Chul Nam; Chung-Soo Kim; Min-Sik Kim
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-08-15       Impact factor: 2.503

8.  (11)C-acetate as a new biomarker for PET/CT in patients with multiple myeloma: initial staging and postinduction response assessment.

Authors:  Chieh Lin; Chi-Lai Ho; Shu-Hang Ng; Po-Nan Wang; Yenlin Huang; Yu-Chun Lin; Tzung-Chih Tang; Shu-Fan Tsai; Alain Rahmouni; Tzu-Chen Yen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-10-16       Impact factor: 9.236

9.  The association of lymph node volume with cervical metastatic lesions in head and neck cancer patients.

Authors:  Ming-Tai Liang; Clayton Chi-Chang Chen; Ching-Ping Wang; Chen-Chi Wang; Whe-Dar Lin; Shih-An Liu
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-09-25       Impact factor: 2.503

10.  Clinical Applications of FDG PET and PET/CT in Head and Neck Cancer.

Authors:  Akram Al-Ibraheem; Andreas Buck; Bernd Joachim Krause; Klemens Scheidhauer; Markus Schwaiger
Journal:  J Oncol       Date:  2009-08-20       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.